In the brains of VWM patients, reduced eIF2B activity leads to increased ATF4 and CHOP activities and reduced levels of phosphorylated eIF2α (p-eIF2α) (Abbink et al., 2019). Here, EIF2B5 is linked to leukoencephalopathy with vanishing white matter.